Emerging EPO and EPO receptor regulators and signal transducers.
about
Erythropoietin Pathway: A Potential Target for the Treatment of DepressionFunctional Selectivity in Cytokine Signaling Revealed Through a Pathogenic EPO MutationErythropoietin signaling regulates heme biosynthesis.Annual banned-substance review: analytical approaches in human sports drug testing.Erythropoietin and IGF-1 signaling synchronize cell proliferation and maturation during erythropoiesisAdvances in understanding erythropoiesis: evolving perspectivesSignal transducer and activator of transcription 5 (STAT5) paralog dose governs T cell effector and regulatory functions.The erythropoietin-derived peptide MK-X and erythropoietin have neuroprotective effects against ischemic brain damage.Targeting EPO and EPO receptor pathways in anemia and dysregulated erythropoiesis.Roles of renal erythropoietin-producing (REP) cells in the maintenance of systemic oxygen homeostasis.Epo reprograms the epigenome of erythroid cells.New strategies to target iron metabolism for the treatment of beta thalassemiaJAK inhibition in the treatment of diabetic kidney disease.2017 Clinical trials update in new treatments of β-thalassemia.A Red Carpet for Iron Metabolism.Hepcidin: Homeostasis and Diseases Related to Iron Metabolism.NiaoDuQing granules relieve chronic kidney disease symptoms by decreasing renal fibrosis and anemia.Efficacy estimation of erythropoiesis-stimulating agents using erythropoietin-deficient anemic mice.Pharmacological targeting of bone marrow mesenchymal stromal/stem cells for the treatment of hematological disorders.Erythropoietin Signaling Regulates Key Epigenetic and Transcription Networks in Fetal Neural Progenitor Cells.What can we learn from ineffective erythropoiesis in thalassemia?Mechanisms of erythrocyte development and regeneration: implications for regenerative medicine and beyond.Efficacy and safety of ruxolitinib in regularly transfused patients with thalassemia: results from a phase 2a study.The Calreticulin control of human stress erythropoiesis is impaired by JAK2V617F in polycythemia vera.Integrative view on how erythropoietin signaling controls transcription patterns in erythroid cells.Effects of Erythropoietin Receptor Activity on Angiogenesis, Tubular Injury and Fibrosis in Acute Kidney Injury: A "U-Shaped" Relationship.Acute blood loss stimulates fibroblast growth factor 23 production.Erythropoietin Receptor-Mediated Molecular Crosstalk Promotes T Cell Immunoregulation and Transplant Survival.The hypoxia inducible factor/erythropoietin (EPO)/EPO receptor pathway is disturbed in a rat model of chronic kidney disease related anemia.Signaling by ErythropoietinErythropoietin activates STAT5Erythropoietin activates Phosphoinositide-3-kinase (PI3K)Erythropoietin activates RASP38α/JNK signaling restrains erythropoiesis by suppressing Ezh2-mediated epigenetic silencing of BimNormal and pathological erythropoiesis in adults: from gene regulation to targeted treatment concepts
P2860
Q26750850-E4BA7E72-6589-4AE4-8CA7-73070290180DQ29147543-FB0C3E95-B24E-4C2B-826D-DE6178B89360Q33817885-9089BD20-4801-4FDB-995D-9B2F57FFD236Q34509038-04955853-1D51-43F9-847D-962CF99C04DEQ36424904-A8B3CE52-953E-4B71-ACA6-CC23EEA08D42Q36803829-93BE522F-5A40-4476-AD49-C10CA2E64703Q36869017-089E92E1-E3BD-4432-B78D-9586C1CC251CQ38399783-D01AD62C-F3BB-4207-973F-77A47E3E39EFQ38595266-3A8FAFDD-3516-4E6A-A952-6355D988F9C2Q38603246-E75F989F-868A-4E07-976E-0D154CCE26DEQ38730271-4F7DE27A-0E7F-4A8F-974A-A0BDBDF88E1AQ38751490-5CCC0EE3-54D4-423F-9BA0-63DF0F52DB38Q38873515-627CD4F7-7F02-4426-8B73-F71E9432E1F3Q38922283-69C3A510-8C47-4A4E-9AE7-D7860D2785AEQ39106718-BA28F63E-4276-49F9-800A-09056A88B534Q39313303-E0F23CF3-FFB1-4028-AD3E-B2C3DDBC6431Q41348527-847C6BE6-C951-4162-A44B-1220D910FB35Q42384360-CC4DAC46-8E08-4A38-A83D-9A707CF8044BQ47138648-7BAD76B2-B975-48CC-A468-EC4E60D7C331Q47146719-ADB110E8-970A-4230-B3BF-6E200D178104Q47885433-2EDA2B0C-CC40-4178-99AF-FA373C19C367Q48268381-9FCA66FD-161A-4087-9B9D-F94FE32BCBABQ48373550-CF7F108F-8063-4762-8B64-B76E841781DBQ49227755-523EF9B3-9727-48DA-8755-E16A99D6120DQ49491478-37B6853D-1579-43EC-80FE-80A175469520Q49541601-98816053-BF38-4632-B708-12201ED5BD49Q50197535-6F4D8E14-F979-431A-9F78-5D15FD9B743FQ51095965-61313094-9CD7-4E19-9384-9CC64D65A7CEQ54454681-45E8B627-14EE-42FB-B80D-69D8D0A6F7E4Q56861031-04D34C51-3078-42BD-9125-148744C20879Q56861032-3B47CA13-BF0B-420D-B39A-990584060400Q56861033-C02E1D25-80AA-4FFC-AE1A-8EA63BA7C94AQ56861034-4DF1BE08-45F2-4DAE-99EC-BFD66C56CF91Q58695531-F0CDC37B-C1FC-4EC1-B775-38330AABE020Q58793895-0DA070BD-2855-4759-8891-65C9C672295A
P2860
Emerging EPO and EPO receptor regulators and signal transducers.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Emerging EPO and EPO receptor regulators and signal transducers.
@ast
Emerging EPO and EPO receptor regulators and signal transducers.
@en
type
label
Emerging EPO and EPO receptor regulators and signal transducers.
@ast
Emerging EPO and EPO receptor regulators and signal transducers.
@en
prefLabel
Emerging EPO and EPO receptor regulators and signal transducers.
@ast
Emerging EPO and EPO receptor regulators and signal transducers.
@en
P2860
P1433
P1476
Emerging EPO and EPO receptor regulators and signal transducers.
@en
P2093
David Kuhrt
Don M Wojchowski
P2860
P304
P356
10.1182/BLOOD-2014-11-575357
P407
P577
2015-04-17T00:00:00Z